<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Previous studies have shown a high prevalence of syndromes in children with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We described four patterns of co-occurring morphological abnormalities indicating new <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> predisposition syndromes </plain></SENT>
<SENT sid="2" pm="."><plain>These patterns were named after their key-abnormalities: <z:hpo ids='HP_0000581'>blepharophimosis</z:hpo> (BP), <z:hpo ids='HP_0000286'>epicanthal folds</z:hpo> (EF), asymmetric lower limbs (LLA) and <z:hpo ids='HP_0011311'>Sydney creases</z:hpo> (SC) pattern </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of our study was to identify structural genomic variants possibly involved in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> predisposition syndromes </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS AND METHODS: In 49 probands (13 from BP, nine from EF, 20 from LLA and seven from SC patterns respectively) karyotyping was performed </plain></SENT>
<SENT sid="5" pm="."><plain>Copy number variation (CNV) in genomic DNA of the probands was analysed to detect microdeletions/-duplications using SNP array </plain></SENT>
<SENT sid="6" pm="."><plain>FISH and quantitative-polymerase chain reaction (q-PCR) experiments were done to validate events identified by cytogenetic and CNV analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Cytogenetic analysis showed an inherited inversion of chromosome 15, inv(15) (q25q26) in a proband with LLA-pattern </plain></SENT>
<SENT sid="8" pm="."><plain>Evaluation of the genes at the breakpoints made it unlikely that these explained the phenotype and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> in this patient </plain></SENT>
<SENT sid="9" pm="."><plain>Eleven CNV events met our inclusion criteria; three inherited CNV events involved an oncogene </plain></SENT>
<SENT sid="10" pm="."><plain>A duplication involving BCL9 was identified in a proband diagnosed with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>A duplication involving PCM1 was identified in a proband diagnosed with <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B-ALL</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Both probands showed the EF-pattern of morphological abnormalities </plain></SENT>
<SENT sid="13" pm="."><plain>A deletion involving TRA@ was identified in two probands from the BP-pattern diagnosed with <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> and <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B-ALL</z:e> respectively </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: We report on structural genomic variants in paediatric <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with newly recognised <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> predisposition syndromes </plain></SENT>
<SENT sid="15" pm="."><plain>We identify three CNV events which we suggest to be susceptibility loci </plain></SENT>
</text></document>